-
Symbol
-
TRVI on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.001 par value per share
-
Latest Disclosed Shares Owned
-
15,074,080 shares
-
Security Ownership %
-
12%
New Enterprise Associates 16, L.P. ownership in Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI)
13 Feb 2026 - New Enterprise Associates 16, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 15,074,080 shares of Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI).
This represents 12% ownership of the company.
In their previous filing dated 20 Mar 2025, New Enterprise Associates 16, L.P. had reported owning 15,074,080 shares, indicating a new holding.